Grey matter alterations associated with cannabis use: Results of a VBM study in heavy cannabis users and healthy controls

NeuroImage

Volumn 59, Issue 4, 2012, Pages 3845-3851

  Cousijn, Janna ^a   Wiers, Reinout W ^a   Ridderinkhof, K Richard ^a   Van den Brink, Wim ^a   Veltman, Dick J ^a   Goudriaan, Anna E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cannabis; Cannabis use disorder; Dependence; MRI; VBM

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABIS; ILLICIT DRUG;

ADULT; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; BRAIN SIZE; CANNABIS ADDICTION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; DRUG USE; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; SUBSTANCE ABUSE; VOXEL BASED MORPHOMETRY; WHITE MATTER;

ADOLESCENT; ADULT; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA ABUSE; NEUROIMAGING; ORGAN SIZE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84855283455     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.09.046     Document Type: Article

References (76)

1. Adamson S.J., Sellman J.D. A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample. Drug Alcohol Rev. 2003, 22:309-315.
2. Adamson S.J., Kay-Lambkin F.J., Baker A.L., Lewin T.J., Thornton L., Kelly B.J., et al. An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug Alcohol Depend. 2010, 110:137-143.
3. American Psychiatry Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Press, Washington DC. 4 ed.
4. Arnone D., Barrick T.R., Chengappa S., Mackay C.E., Clark C.A., Abou-Saleh M.T. Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics. NeuroImage 2008, 41:1067-1074.
5. Ashburner J. A fast diffeomorphic image registration algorithm. NeuroImage 2007, 38:95-113.
6. Ashburner J., Friston K.J. Unified segmentation. NeuroImage 2005, 26:839-851.
7. Ashtari M., Cervellione K., Cottone J., Ardekani B.A., Sevy S., Kumra S. Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use. J. Psychiatr. Res. 2009, 43:189-204.
8. Ashtari M., Avants B., Cyckowski L., Cervellione K.L., Roofeh D., Cook P., et al. Medial temporal structures and memory functions in adolescents with heavy cannabis use. J. Psychiatr. Res. 2011, 10.1016/j.jpsychires.2011.01.004.
9. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
10. Bennett A. Cannabis: a harm reduction perspective. A Cannabis Reader: Global Issues and Local Experiences, Monograph Series 8 2008, 171-183. European Monitoring Centre for Drugs and Drug Addiction, Lisbon. R.S. Sznitman, B. Olsson, R. Room (Eds.).
11. Berge D., Carmona S., Rovira M., Bulbena A., Salgado P., Vilarroya O. Gray matter volume deficits and correlation with insight and negative symptoms in first-psychotic-episode subjects. Acta Psychiatr. Scand. 2011, 123:431-439.
12. Block R.I., O'Leary D.S., Ehrhardt J.C., Augustinack J.C., Ghoneim M.M., Arndt S., et al. Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport 2000, 11:491-496.
13. Bolla K.I., Eldreth D.A., Matochik J.A., Cadet J.L. Neural substrates of faulty decision-making in abstinent marijuana users. NeuroImage 2005, 26:480-492.
14. Burns H.D., Van Laere K., Sanabria-Bohorquez S., Hamill T.G., Bormans G., Eng W.S., et al. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:9800-9805.
15. Chambers R.A., Taylor J.R., Potenza M.N. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am. J. Psychiatry 2003, 160:1041-1052.
16. Conturo T.E., Lori N.F., Cull T.S., Akbudak E., Snyder A.Z., Shimony J.S., et al. Tracking neuronal fiber pathways in the living human brain. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:10422-10427.
17. Cousijn J., Goudriaan A.E., Wiers R.W. Reaching out towards cannabis: approach-bias in heavy cannabis users predicts changes in cannabis use. Addiction 2011, 10.1111/j.360-0443.2011.03475.x.
18. Cuadra M.B., Cammoun L., Butz T., Cuisenaire O., Thiran J.P. Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images. IEEE Trans. Med. Imaging 2005, 24:1548-1565.
19. Delisi L.E., Bertisch H.C., Szulc K.U., Majcher M., Brown K., Bappal A., et al. A preliminary DTI study showing no brain structural change associated with adolescent cannabis use. Harm Reduct. J. 2006, 3:17.
20. Demirakca T., Sartorius A., Ende G., Meyer N., Welzel H., Skopp G., et al. Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol. Drug Alcohol Depend. 2011, 114:242-245.
21. Downer E., Boland B., Fogarty M., Campbell V. Delta 9-tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurones via activation of the CB1 receptor. Neuroreport 2001, 12:3973-3978.
22. Ehrenreich H., Rinn T., Kunert H.J., Moeller M.R., Poser W., Schilling L., et al. Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology (Berl.) 1999, 142:295-301.
23. Filbey F.M., Schacht J.P., Myers U.S., Chavez R.S., Hutchison K.E. Marijuana craving in the brain. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:13016-13021.
24. Frodl T., Reinhold E., Koutsouleris N., Reiser M., Meisenzahl E.M. Interaction of childhood stress with hippocampus and prefrontal cortex volume reduction in major depression. J. Psychiatr. Res. 2010, 44:799-807.
25. Fusar-Poli P., Borgwardt S., Crescini A., Deste G., Kempton M.J., Lawrie S., et al. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci. Biobehav. Rev. 2011, 35:1175-1185.
26. Gaoni Y., Mechoulam R. The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish. J. Am. Chem. Soc. 1971, 93:217-224.
27. Gaser C. Partial volume segmentation with adaptive maximum a posteriori (MAP) approach. NeuroImage 2009, 47(S1):S39-S42.
28. Gruber S.A., Yurgelun-Todd D.A. Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation. Brain Res. 2005, 23:107-118.
29. Hayano F., Nakamura M., Asami T., Uehara K., Yoshida T., Roppongi T., et al. Smaller amygdala is associated with anxiety in patients with panic disorder. Psychiatry Clin. Neurosci. 2009, 63:266-276.
30. Heath R.G., Fitzjarrell A.T., Fontana C.J., Garey R.E. Cannabis sativa: effects on brain function and ultrastructure in rhesus monkeys. Biol. Psychiatry 1980, 15:657-690.
31. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict. 1991, 86:1119-1127.
32. Hill S.Y., Muddasani S., Prasad K., Nutche J., Steinhauer S.R., Scanlon J., et al. Cerebellar volume in offspring from multiplex alcohol dependence families. Biol. Psychiatry 2007, 61:41-47.
33. Jacobus J., McQueeny T., Bava S., Schweinsburg B.C., Frank L.R., Yang T.T., et al. White matter integrity in adolescents with histories of marijuana use and binge drinking. Neurotoxicol. Teratol. 2009, 31:349-355.
34. Jager G., Van Hell H.H., De Win M.M., Kahn R.S., Van Den Brink W., Van Ree J.M., et al. Effects of frequent cannabis use on hippocampal activity during an associative memory task. Eur. Neuropsychopharmacol. 2007, 17:289-297.
35. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
36. Kooij J.J., Buitelaar J.K., van den Oord E.J., Furer J.W., Rijnders C.A., Hodiamont P.P. Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol. Med. 2005, 35:817-827.
37. Kwon J.S., Shin Y.W., Kim C.W., Kim Y.I., Youn T., Han M.H., et al. Similarity and disparity of obsessive-compulsive disorder and schizophrenia in MR volumetric abnormalities of the hippocampus-amygdala complex. J. Neurol. Neurosurg. Psychiatry 2003, 74:962-964.
38. Lawston J., Borella A., Robinson J.K., Whitaker-Azmitia P.M. Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2. Brain Res. 2000, 877:407-410.
39. Lorenzetti V., Lubman D.I., Whittle S., Solowij N., Yucel M. Structural MRI findings in long-term cannabis users: what do we know?. Subst. Use Misuse 2010, 45:1787-1808.
40. Manjon J.V., Coupe P., Marti-Bonmati L., Collins D.L., Robles M. Adaptive non-local means denoising of MR images with spatially varying noise levels. J. Magn. Reson. Imaging 2010, 31:192-203.
41. Martin-Santos R., Fagundo A.B., Crippa J.A., Atakan Z., Bhattacharyya S., Allen P., et al. Neuroimaging in cannabis use: a systematic review of the literature. Psychol. Med. 2010, 40:383-398.
42. Matochik J.A., Eldreth D.A., Cadet J.L., Bolla K.I. Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend. 2005, 77:23-30.
43. Medina K.L., Schweinsburg A.D., Cohen-Zion M., Nagel B.J., Tapert S.F. Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicol. Teratol. 2007, 29:141-152.
44. Medina K.L., Nagel B.J., Park A., McQueeny T., Tapert S.F. Depressive symptoms in adolescents: associations with white matter volume and marijuana use. J. Child Psychol. Psychiatry 2007, 48:592-600.
45. Medina K.L., McQueeny T., Nagel B.J., Hanson K.L., Yang T.T., Tapert S.F. Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects. Addict. Biol. 2009, 14:457-468.
46. Medina K.L., Nagel B.J., Tapert S.F. Abnormal cerebellar morphometry in abstinent adolescent marijuana users. Psychiatry Res. 2010, 182:152-159.
47. Nelson H.E. National Adult Reading Test 1984, NFER-Nelson, Windsor, UK.
48. Nestor L., Roberts G., Garavan H., Hester R. Deficits in learning and memory: parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users. NeuroImage 2008, 40:1328-1339.
49. Nielsen F.Å., Hansen L.K. Automatic anatomical labeling of Talairach coordinates and generation of volumes of interest via the BrainMap database. NeuroImage 2 (Supplement 1) 2002.
50. Peng J., Liu J., Nie B., Li Y., Shan B., Wang G., et al. Cerebral and cerebellar gray matter reduction in first-episode patients with major depressive disorder: a voxel-based morphometry study. Eur. J. Radiol. 2010, 10.1016/j.ejrad.2010.04.006.
51. Pope H.G., Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. JAMA 1996, 275:521-527.
52. Pope H.G., Jacobs A., Mialet J.P., Yurgelun-Todd D., Gruber S. Evidence for a sex-specific residual effect of cannabis on visuospatial memory. Psychother. Psychosom. 1997, 66:179-184.
53. Pope H.G., Gruber A.J., Hudson J.I., Huestis M.A., Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch. Gen. Psychiatry 2001, 58:909-915.
54. Rajapakse J.C., Giedd J.N., Rapoport J.L. Statistical approach to segmentation of single-channel cerebral MR images. IEEE Trans. Med. Imaging 1997, 16:176-186.
55. Roese N.J., Jamieson D.W. Twenty years of bogus pipeline research: a critical review and meta-analysis. Psychol. Bull. 1993, 114:363-375.
56. Sasayama D., Hayashida A., Yamasue H., Harada Y., Kaneko T., Kasai K., et al. Neuroanatomical correlates of attention-deficit-hyperactivity disorder accounting for comorbid oppositional defiant disorder and conduct disorder. Psychiatry Clin. Neurosci. 2010, 64:394-402.
57. Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R., Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction 1993, 88:791-804.
58. Scallet A.C., Uemura E., Andrews A., Ali S.F., McMillan D.E., Paule M.G., et al. Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC). Brain Res. 1987, 436:193-198.
59. Schmand B., Bakker D., Saan R., Louman J. The Dutch Reading Test for Adults: a measure of premorbid intelligence level. Tijdschr. Gerontol. Geriatr. 1991, 22:15-19.
60. Seidman L.J., Biederman J., Liang L., Valera E.M., Monuteaux M.C., Brown A., et al. Gray matter alterations in adults with attention-deficit/hyperactivity disorder identified by voxel based morphometry. Biol. Psychiatry 2011, 69:857-866.
61. Shattuck D.W., Mirza M., Adisetiyo V., Hojatkashani C., Salamon G., Narr K.L., et al. Construction of a 3D probabilistic atlas of human cortical structures. NeuroImage 2008, 39:1064-1080.
62. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20):22-33. (quiz 4-57).
63. Sim M.E., Lyoo I.K., Streeter C.C., Covell J., Sarid-Segal O., Ciraulo D.A., et al. Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects. Neuropsychopharmacology 2007, 32:2229-2237.
64. Skosnik P.D., Edwards C.R., O'Donnell B.F., Steffen A., Steinmetz J.E., Hetrick W.P. Cannabis use disrupts eyeblink conditioning: evidence for cannabinoid modulation of cerebellar-dependent learning. Neuropsychopharmacology 2008, 33:1432-1440.
65. Solowij N., Battisti R. The chronic effects of cannabis on memory in humans: a review. Curr. Drug Abuse Rev. 2008, 1:81-98.
66. Solowij N., Michie P.T., Fox A.M. Differential impairments of selective attention due to frequency and duration of cannabis use. Biol. Psychiatry 1995, 37:731-739.
67. Solowij N., Stephens R.S., Roffman R.A., Babor T., Kadden R., Miller M., et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002, 287:1123-1131.
68. Solowij N., Yucel M., Respondek C., Whittle S., Lindsay E., Pantelis C., et al. Cerebellar white-matter changes in cannabis users with and without schizophrenia. Psychol. Med 2011, 10.1017/S003329171100050X.
69. Tohka J., Zijdenbos A., Evans A. Fast and robust parameter estimation for statistical partial volume models in brain MRI. NeuroImage 2004, 23:84-97.
70. Tzilos G.K., Cintron C.B., Wood J.B., Simpson N.S., Young A.D., Pope H.G., et al. Lack of hippocampal volume change in long-term heavy cannabis users. Am. J. Addict. 2005, 14:64-72.
71. United Nations Office on Drugs and Crime, editors. World Drug Report. New York: United Nations; 2009.
72. Whitlow C.T., Liguori A., Livengood L.B., Hart S.L., Mussat-Whitlow B.J., Lamborn C.M., et al. Long-term heavy marijuana users make costly decisions on a gambling task. Drug Alcohol Depend. 2004, 76:107-111.
73. Wise L.E., Thorpe A.J., Lichtman A.H. Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol. Neuropsychopharmacology 2009, 34:2072-2080.
74. Worsley K.J., Marrett S., Neelin P., Vandal A.C., Friston K.J., Evans A.C. A unified statistical approach for determining significant signals in images of cerebral activation. Hum. Brain Mapp. 1996, 4:58-73.
75. Yucel M., Solowij N., Respondek C., Whittle S., Fornito A., Pantelis C., et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch. Gen. Psychiatry 2008, 65:694-701.
76. Yucel M., Zalesky A., Takagi M.J., Bora E., Fornito A., Ditchfield M., et al. White-matter abnormalities in adolescents with long-term inhalant and cannabis use: a diffusion magnetic resonance imaging study. J. Psychiatry Neurosci. 2010, 35:409-412.